FITC-Linked Polyclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)

Host

Clone Number

Ig Isotype

Organism species

Homo sapiens (Human)

Concentration

500µg/mL

Application

WB; IHC; ICC; IF.

Alternative Names

SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15

Item Names

Suppression Of Tumorigenicity 14

Research Area

Tumor immunity;

Citation

Buffer Formulation

PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.

Immunogen

Usage

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Traits

Liquid

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography